Novocure Ltd (NVCR.OQ)
16 Feb 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
- BRIEF-Novocure Secures New $150 Mln Non-Dilutive Term Loan Financing
- BRIEF-Minerva Neurosciences Names Remy Luthringer As Executive Chairman
- BRIEF-Novocure Announces Q4 And FY17 Operating Statistics And Preliminary Revenue
- BRIEF-Novocure Receives FDA IDE Approval For Its PANOVA 3 Phase 3 Pivotal Clinical Trial In Advanced Pancreatic Cancer
- BRIEF-Novocure Receives Reimbursement Approval For Optune In Japan For Treatment Of Glioblastoma